Lv4
460 积分 2023-10-19 加入
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
21天前
已完结
Controversies in metastatic hormone‐sensitive prostate cancer
21天前
已完结
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma
28天前
已完结
Pathologic and molecular insights in nodal T-follicular helper cell lymphomas
28天前
已完结
PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging
29天前
已完结
A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder: efficacy of pralatrexate in primary refractory disease and review of the literature
1个月前
已完结
Survival following salvage therapy for primary refractory peripheral T‐cell lymphomas (PTCL)
1个月前
已完结
Personalized intensification of treatment for hormone-sensitive prostate cancer
2个月前
已完结
Antithymocyte globulin combined with cyclosporine A down-regulates T helper 1 cells by modulating T cell immune response cDNA 7 in aplastic anemia
4个月前
已完结
Relationship between Changes of Lymphocyte Subsets and Early Hematologic Response in Immunosuppressive Therapy of Severe Aplastic Anemia Patients
4个月前
已关闭
皖公网安备34019202002308
